REPROS THERAPEUTICS INC. (RPRX) is a publicly traded company in the Unknown sector. Across all available filings, 46 corporate insiders have executed 600 transactions totaling $1.1B, demonstrating a bearish sentiment with -$720.9M in net insider flow. The most recent transaction on Jan 23, 2026 involved a sale of 20,000 shares valued at $805.1K.
No significant insider buying has been recorded for RPRX in the recent period.
No significant insider selling has been recorded for RPRX in the recent period.
Based on recent SEC filings, insider sentiment for RPRX is bearish with an Insider Alignment Score of 18/100 and a net flow of -$720.9M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at REPROS THERAPEUTICS INC. (RPRX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 46 insiders are actively trading RPRX stock, having executed 600 transactions in the past 90 days. The most active insider is Capital Advisors, L.l.c. Adage (Executive), who has made 2 transactions totaling $320.7M.
Get notified when executives and directors at RPRX file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jan 23, 2026 | Urist Marshall | EVP, Research & Investments | Sale | 20,000 | $40.26 | $805.1K | Large |
| Jan 9, 2026 | Urist Marshall | EVP, Research & Investments | Sale | 20,000 | $40.78 | $815.6K | Large |
| Dec 26, 2025 | Urist Marshall | Executive | Sale | 20,000 | $39.32 | $786.4K | Large |
| Dec 19, 2025 | Urist Marshall | Executive | Sale | 20,000 | $38.38 | $767.6K | Large |
| Dec 18, 2025 | W. Lloyd George | Executive | Sale | 30,654 | $38.50 | $1.2M | Large |
| Dec 17, 2025 | W. Lloyd George | Executive | Sale | 79,346 | $38.57 | $3.1M | Large |
| Dec 16, 2025 | Urist Marshall | Executive | Sale | 20,000 | $38.32 | $766.4K | Large |
| Dec 15, 2025 | P. Coyne Terrance | Executive | Sale | 65,832 | $38.36 | $2.5M | Large |
| Dec 15, 2025 | P. Coyne Terrance | Executive | Sale | 3,750 | $38.36 | $143.8K | |
| Dec 5, 2025 | Urist Marshall | Executive | Sale | 18,242 | $39.15 | $714.2K | Large |
| Dec 5, 2025 | Urist Marshall | Executive | Sale | 23,334 | $39.15 | $913.5K | Large |
| Dec 3, 2025 | W. Lloyd George | Executive | Sale | 110,000 | $39.77 | $4.4M | Large |
| Dec 1, 2025 | Urist Marshall | Executive | Sale | 23,333 | $39.93 | $931.7K | Large |
| Dec 1, 2025 | Urist Marshall | Executive | Sale | 18,242 | $39.90 | $727.9K | Large |
| Dec 1, 2025 | P. Coyne Terrance | Executive | Sale | 65,832 | $39.87 | $2.6M | Large |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 239 | $920.6M | 80.2% |
Purchase(P) | 156 | $199.7M | 17.4% |
Exercise (Options)(X) | 15 | $25.3M | 2.2% |
Award(A) | 101 | $1.4M | 0.1% |
Exercise(M) | 5 | $317.6K | 0.0% |
Payment(F) | 3 | $221.6K | 0.0% |
Tender(U) | 6 | $110.8K | 0.0% |
Disposition(D) | 5 | $93.1K | 0.0% |
Conversion(C) | 44 | $0 | 0.0% |
Other(J) | 25 | $0 | 0.0% |
Gift(G) | 1 | $0 | 0.0% |
Insider selling pressure at REPROS THERAPEUTICS INC. has increased, with 46 insiders executing 600 transactions across all time. Total sales of $920.6M significantly outpace purchases of $199.7M, resulting in a net outflow of $720.9M. This selling activity appears largely discretionary, which may warrant closer attention from investors.